Lonza to enhance commercial antibody-drug conjugate supply capacity
A new cGMP filling line is set to be built…
A new cGMP filling line is set to be built at Lonza’s Stein site in Switzerland, expanding filling capacity and enabling the handling and filling of bioconjugates for commercial supply.